Epigenetic Modifications as Therapeutic Targets

Author(s): Yi-Chao Zheng, Si-Qi Feng

Journal Name: Current Drug Targets

Volume 21 , Issue 11 , 2020


Become EABM
Become Reviewer
Call for Editor

[1]
Goldberg AD, Allis CD, Bernstein E. Epigenetics: A Landscape Takes Shape. Cell 2007; 128: 635-8.
[2]
Pechalrieu D, Etievant C, Arimondo PB. DNA methyltransferase inhibitors in cancer: From pharmacology to translational studies. Biochemical Pharmacology 2017; 129.
[3]
McClure JJ, Li X, Chou CJ. Chapter Six - Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics. In: Tew KD, Fisher PB, ed.^eds., Advances in Cancer Research. Academic Press 2018; pp. 183-211.
[4]
Rothbart SB, Baylin SB. Epigenetic Therapy for Epithelioid Sarcoma. Cell 2020; 181: 211.


free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 11
Year: 2020
Published on: 27 July, 2020
Page: [1046 - 1046]
Pages: 1
DOI: 10.2174/138945012111200727122724

Article Metrics

PDF: 21
HTML: 5